 | • レポートコード：GIR201115207 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、皮下免疫療法の世界市場を調査対象にし、皮下免疫療法の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（喘息、アレルギー性鼻炎、毒アレルギー、食物アレルギー）、用途別分析（病院薬局、オンライン薬局、小売薬局）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Anergis、Allergy Therapeutics、HAL Allergy Group、Laboratorios LETI、Merck、Stallergenes Greer、ALK-Abello ・企業別売上、市場シェア ・皮下免疫療法の地域別市場分析 ・皮下免疫療法の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・皮下免疫療法のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・皮下免疫療法のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・皮下免疫療法の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・皮下免疫療法の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・皮下免疫療法の種類別市場規模2015-2020：喘息、アレルギー性鼻炎、毒アレルギー、食物アレルギー ・皮下免疫療法の用途別市場規模2015-2020：病院薬局、オンライン薬局、小売薬局 ・皮下免疫療法の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Subcutaneous Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Subcutaneous Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Subcutaneous Immunotherapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Subcutaneous Immunotherapy market has been segmented into:
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
By Application, Subcutaneous Immunotherapy has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Subcutaneous Immunotherapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Subcutaneous Immunotherapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Subcutaneous Immunotherapy market.
The report offers in-depth assessment of the growth and other aspects of the Subcutaneous Immunotherapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Subcutaneous Immunotherapy Market Share Analysis
Subcutaneous Immunotherapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Subcutaneous Immunotherapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Subcutaneous Immunotherapy sales, revenue and market share for each player covered in this report.
The major players covered in Subcutaneous Immunotherapy are:
Anergis
Allergy Therapeutics
HAL Allergy Group
Laboratorios LETI
Merck
Stallergenes Greer
ALK-Abello
1 Subcutaneous Immunotherapy Market Overview
1.1 Product Overview and Scope of Subcutaneous Immunotherapy
1.2 Classification of Subcutaneous Immunotherapy by Type
1.2.1 Global Subcutaneous Immunotherapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Subcutaneous Immunotherapy Revenue Market Share by Type in 2019
1.2.3 Asthma
1.2.4 Allergic Rhinitis
1.2.5 Venom Allergy
1.2.6 Food Allergy
1.3 Global Subcutaneous Immunotherapy Market by Application
1.3.1 Overview: Global Subcutaneous Immunotherapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Subcutaneous Immunotherapy Market by Regions
1.4.1 Global Subcutaneous Immunotherapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Subcutaneous Immunotherapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Subcutaneous Immunotherapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Subcutaneous Immunotherapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Subcutaneous Immunotherapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Subcutaneous Immunotherapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Subcutaneous Immunotherapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Anergis
2.1.1 Anergis Details
2.1.2 Anergis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Anergis SWOT Analysis
2.1.4 Anergis Product and Services
2.1.5 Anergis Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Allergy Therapeutics
2.2.1 Allergy Therapeutics Details
2.2.2 Allergy Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Allergy Therapeutics SWOT Analysis
2.2.4 Allergy Therapeutics Product and Services
2.2.5 Allergy Therapeutics Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 HAL Allergy Group
2.3.1 HAL Allergy Group Details
2.3.2 HAL Allergy Group Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 HAL Allergy Group SWOT Analysis
2.3.4 HAL Allergy Group Product and Services
2.3.5 HAL Allergy Group Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Laboratorios LETI
2.4.1 Laboratorios LETI Details
2.4.2 Laboratorios LETI Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Laboratorios LETI SWOT Analysis
2.4.4 Laboratorios LETI Product and Services
2.4.5 Laboratorios LETI Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Stallergenes Greer
2.6.1 Stallergenes Greer Details
2.6.2 Stallergenes Greer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Stallergenes Greer SWOT Analysis
2.6.4 Stallergenes Greer Product and Services
2.6.5 Stallergenes Greer Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 ALK-Abello
2.7.1 ALK-Abello Details
2.7.2 ALK-Abello Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 ALK-Abello SWOT Analysis
2.7.4 ALK-Abello Product and Services
2.7.5 ALK-Abello Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Subcutaneous Immunotherapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Subcutaneous Immunotherapy Players Market Share
3.2.2 Top 10 Subcutaneous Immunotherapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Subcutaneous Immunotherapy Revenue and Market Share by Regions
4.2 North America Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
4.3 Europe Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
4.5 South America Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
5 North America Subcutaneous Immunotherapy Revenue by Countries
5.1 North America Subcutaneous Immunotherapy Revenue by Countries (2015-2020)
5.2 USA Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
5.3 Canada Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
6 Europe Subcutaneous Immunotherapy Revenue by Countries
6.1 Europe Subcutaneous Immunotherapy Revenue by Countries (2015-2020)
6.2 Germany Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
6.3 UK Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
6.4 France Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
6.5 Russia Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
6.6 Italy Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Subcutaneous Immunotherapy Revenue by Countries
7.1 Asia-Pacific Subcutaneous Immunotherapy Revenue by Countries (2015-2020)
7.2 China Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
7.3 Japan Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
7.4 Korea Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
7.5 India Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
8 South America Subcutaneous Immunotherapy Revenue by Countries
8.1 South America Subcutaneous Immunotherapy Revenue by Countries (2015-2020)
8.2 Brazil Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Subcutaneous Immunotherapy by Countries
9.1 Middle East & Africa Subcutaneous Immunotherapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
9.3 UAE Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Subcutaneous Immunotherapy Revenue and Market Share by Type (2015-2020)
10.2 Global Subcutaneous Immunotherapy Market Forecast by Type (2019-2024)
10.3 Asthma Revenue Growth Rate (2015-2025)
10.4 Allergic Rhinitis Revenue Growth Rate (2015-2025)
10.5 Venom Allergy Revenue Growth Rate (2015-2025)
10.6 Food Allergy Revenue Growth Rate (2015-2025)
11 Global Subcutaneous Immunotherapy Market Segment by Application
11.1 Global Subcutaneous Immunotherapy Revenue Market Share by Application (2015-2020)
11.2 Subcutaneous Immunotherapy Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Online Pharmacies Revenue Growth (2015-2020)
11.5 Retail Pharmacies Revenue Growth (2015-2020)
12 Global Subcutaneous Immunotherapy Market Size Forecast (2021-2025)
12.1 Global Subcutaneous Immunotherapy Market Size Forecast (2021-2025)
12.2 Global Subcutaneous Immunotherapy Market Forecast by Regions (2021-2025)
12.3 North America Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
12.4 Europe Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
12.6 South America Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Subcutaneous Immunotherapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Subcutaneous Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Subcutaneous Immunotherapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Subcutaneous Immunotherapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Anergis Corporate Information, Location and Competitors
Table 6. Anergis Subcutaneous Immunotherapy Major Business
Table 7. Anergis Subcutaneous Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 8. Anergis SWOT Analysis
Table 9. Anergis Subcutaneous Immunotherapy Product and Solutions
Table 10. Anergis Subcutaneous Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Allergy Therapeutics Corporate Information, Location and Competitors
Table 12. Allergy Therapeutics Subcutaneous Immunotherapy Major Business
Table 13. Allergy Therapeutics Subcutaneous Immunotherapy Total Revenue (USD Million) (2018-2019)
Table 14. Allergy Therapeutics SWOT Analysis
Table 15. Allergy Therapeutics Subcutaneous Immunotherapy Product and Solutions
Table 16. Allergy Therapeutics Subcutaneous Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. HAL Allergy Group Corporate Information, Location and Competitors
Table 18. HAL Allergy Group Subcutaneous Immunotherapy Major Business
Table 19. HAL Allergy Group Subcutaneous Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 20. HAL Allergy Group SWOT Analysis
Table 21. HAL Allergy Group Subcutaneous Immunotherapy Product and Solutions
Table 22. HAL Allergy Group Subcutaneous Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Laboratorios LETI Corporate Information, Location and Competitors
Table 24. Laboratorios LETI Subcutaneous Immunotherapy Major Business
Table 25. Laboratorios LETI Subcutaneous Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 26. Laboratorios LETI SWOT Analysis
Table 27. Laboratorios LETI Subcutaneous Immunotherapy Product and Solutions
Table 28. Laboratorios LETI Subcutaneous Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Subcutaneous Immunotherapy Major Business
Table 31. Merck Subcutaneous Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Subcutaneous Immunotherapy Product and Solutions
Table 34. Merck Subcutaneous Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Stallergenes Greer Corporate Information, Location and Competitors
Table 36. Stallergenes Greer Subcutaneous Immunotherapy Major Business
Table 37. Stallergenes Greer Subcutaneous Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 38. Stallergenes Greer SWOT Analysis
Table 39. Stallergenes Greer Subcutaneous Immunotherapy Product and Solutions
Table 40. Stallergenes Greer Subcutaneous Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. ALK-Abello Corporate Information, Location and Competitors
Table 42. ALK-Abello Subcutaneous Immunotherapy Major Business
Table 43. ALK-Abello Subcutaneous Immunotherapy Total Revenue (USD Million) (2017-2018)
Table 44. ALK-Abello SWOT Analysis
Table 45. ALK-Abello Subcutaneous Immunotherapy Product and Solutions
Table 46. ALK-Abello Subcutaneous Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Subcutaneous Immunotherapy Revenue (Million USD) by Players (2015-2020)
Table 48. Global Subcutaneous Immunotherapy Revenue Share by Players (2015-2020)
Table 49. Global Subcutaneous Immunotherapy Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Subcutaneous Immunotherapy Revenue Market Share by Regions (2015-2020)
Table 51. North America Subcutaneous Immunotherapy Revenue by Countries (2015-2020)
Table 52. North America Subcutaneous Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 53. Europe Subcutaneous Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Subcutaneous Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Subcutaneous Immunotherapy Revenue by Countries (2015-2020)
Table 56. South America Subcutaneous Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Subcutaneous Immunotherapy Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Subcutaneous Immunotherapy Revenue Market Share by Countries (2015-2020)
Table 59. Global Subcutaneous Immunotherapy Revenue (Million USD) by Type (2015-2020)
Table 60. Global Subcutaneous Immunotherapy Revenue Share by Type (2015-2020)
Table 61. Global Subcutaneous Immunotherapy Revenue Forecast by Type (2021-2025)
Table 62. Global Subcutaneous Immunotherapy Revenue by Application (2015-2020)
Table 63. Global Subcutaneous Immunotherapy Revenue Share by Application (2015-2020)
Table 64. Global Subcutaneous Immunotherapy Revenue Forecast by Application (2021-2025)
Table 65. Global Subcutaneous Immunotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Subcutaneous Immunotherapy Picture
Figure 2. Global Subcutaneous Immunotherapy Revenue Market Share by Type in 2019
Figure 3. Asthma Picture
Figure 4. Allergic Rhinitis Picture
Figure 5. Venom Allergy Picture
Figure 6. Food Allergy Picture
Figure 7. Subcutaneous Immunotherapy Revenue Market Share by Application in 2019
Figure 8. Hospital Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Global Subcutaneous Immunotherapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Subcutaneous Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Subcutaneous Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Subcutaneous Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Subcutaneous Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Subcutaneous Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Subcutaneous Immunotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Subcutaneous Immunotherapy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Subcutaneous Immunotherapy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Subcutaneous Immunotherapy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Subcutaneous Immunotherapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Subcutaneous Immunotherapy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Subcutaneous Immunotherapy Revenue Market Share by Regions in 2018
Figure 25. North America Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 28. South America Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 30. North America Subcutaneous Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Subcutaneous Immunotherapy Revenue Market Share by Countries in 2019
Figure 32. USA Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Subcutaneous Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Subcutaneous Immunotherapy Revenue Market Share by Countries in 2019
Figure 37. Germany Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 38. UK Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 39. France Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Subcutaneous Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Subcutaneous Immunotherapy Revenue Market Share by Countries in 2019
Figure 44. China Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 47. India Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 49. South America Subcutaneous Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Subcutaneous Immunotherapy Revenue Market Share by Countries in 2019
Figure 51. Brazil Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Subcutaneous Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Subcutaneous Immunotherapy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Subcutaneous Immunotherapy Revenue and Growth Rate (2015-2020)
Figure 59. Global Subcutaneous Immunotherapy Revenue Share by Type (2015-2020)
Figure 60. Global Subcutaneous Immunotherapy Revenue Share by Type in 2019
Figure 61. Global Subcutaneous Immunotherapy Market Share Forecast by Type (2021-2025)
Figure 62. Global Asthma Revenue Growth Rate (2015-2020)
Figure 63. Global Allergic Rhinitis Revenue Growth Rate (2015-2020)
Figure 64. Global Venom Allergy Revenue Growth Rate (2015-2020)
Figure 65. Global Food Allergy Revenue Growth Rate (2015-2020)
Figure 66. Global Subcutaneous Immunotherapy Revenue Share by Application (2015-2020)
Figure 67. Global Subcutaneous Immunotherapy Revenue Share by Application in 2019
Figure 68. Global Subcutaneous Immunotherapy Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 71. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Subcutaneous Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Subcutaneous Immunotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Subcutaneous Immunotherapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
Figure 76. Europe Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
Figure 78. South America Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Subcutaneous Immunotherapy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
舌下免疫療法の世界市場 2020年 Market Overview The global Sublingual Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sublingual Immunothe…- アレルギー免疫療法の世界市場 2020年 Market Overview The Allergy Immunotherapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- アレルギー性鼻炎免疫療法の世界市場 2020年 Market Overview The global Allergic Rhinitis Immunotherapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Allergic Rh…
- 食物アレルギー免疫療法の世界市場 2020年 Market Overview The global Food Allergy Immunotherapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Food Allergy Imm…
- 喘息免疫療法の世界市場 2020年 Market Overview The global Asthma Immunotherapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Asthma Immunotherapies…